Factors associated with 5-year survival of combined hepatocellular and cholangiocarcinoma

来源 :世界肝病学杂志:英文版(电子版) | 被引量 : 0次 | 上传用户:CPhoenixEx
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
BACKGROUND Combined hepatocellular and cholangiocarcinoma(HCC/CC)is a rare primary hepatic malignancy which carries a poor prognosis due to its aggressive nature.Few centers have enough cases to draw definitive conclusions and there is limited understandi
其他文献
BACKGROUND Malnutrition in cirrhotic patients is correlated with mortality and a better response to liver transplantation.However,recovery of the nutritional st
BACKGROUND Genetic factors play an important role in the pathogenesis and development of metabolic dysfunction-associated fatty liver disease(MAFLD).AIM To stud
Metabolic associated fatty liver disease(MAFLD),previously termed nonalcoholic fatty liver disease,is the leading global cause of liver disease and is fast beco
BACKGROUND Ascites is one of the most common complications of cirrhosis,placing a significant burden on the healthcare system.Data regarding the optimal time of
BACKGROUND Hepatectomy with inflow occlusion results in ischemia-reperfusion injury;however,pharmacological preconditioning can prevent such injury and optimize
BACKGROUND The oral nucleos(t)ide analogue,entecavir(ETV)was demonstrated to reduce the rate of hepatocellular carcinoma(HCC)in patients with hepatitis B virus(
An adequate balance between electrolytes and clear water is of paramount importance to maintaining physiologic homeostasis.Natremia imbalance and,in particular,
BACKGROUND Direct-acting antiviral(DAA)therapy regimens are highly effective at eliminating hepatitis C virus(HCV)infection but rates of sustained virologic res
Intrahepatic cholangiocarcinoma(iCCA)is a heterogeneous primary liver cancer,and currently there exist only a few options of targeted therapy.Histopathologicall
BACKGROUND Anti-programmed death therapy has thrust immunotherapy into the spotlight.However,such therapy has a modest response in hepatocellular carcinoma(HCC)